Correlation Between Amplia Therapeutics and PsyBio Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Amplia Therapeutics and PsyBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amplia Therapeutics and PsyBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amplia Therapeutics Limited and PsyBio Therapeutics Corp, you can compare the effects of market volatilities on Amplia Therapeutics and PsyBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amplia Therapeutics with a short position of PsyBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amplia Therapeutics and PsyBio Therapeutics.

Diversification Opportunities for Amplia Therapeutics and PsyBio Therapeutics

0.3
  Correlation Coefficient

Weak diversification

The 3 months correlation between Amplia and PsyBio is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Amplia Therapeutics Limited and PsyBio Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PsyBio Therapeutics Corp and Amplia Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amplia Therapeutics Limited are associated (or correlated) with PsyBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PsyBio Therapeutics Corp has no effect on the direction of Amplia Therapeutics i.e., Amplia Therapeutics and PsyBio Therapeutics go up and down completely randomly.

Pair Corralation between Amplia Therapeutics and PsyBio Therapeutics

Assuming the 90 days horizon Amplia Therapeutics is expected to generate 14.56 times less return on investment than PsyBio Therapeutics. But when comparing it to its historical volatility, Amplia Therapeutics Limited is 6.98 times less risky than PsyBio Therapeutics. It trades about 0.05 of its potential returns per unit of risk. PsyBio Therapeutics Corp is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  0.01  in PsyBio Therapeutics Corp on September 2, 2024 and sell it today you would earn a total of  0.00  from holding PsyBio Therapeutics Corp or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy98.46%
ValuesDaily Returns

Amplia Therapeutics Limited  vs.  PsyBio Therapeutics Corp

 Performance 
       Timeline  
Amplia Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Amplia Therapeutics Limited are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting primary indicators, Amplia Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
PsyBio Therapeutics Corp 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in PsyBio Therapeutics Corp are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting fundamental drivers, PsyBio Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Amplia Therapeutics and PsyBio Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Amplia Therapeutics and PsyBio Therapeutics

The main advantage of trading using opposite Amplia Therapeutics and PsyBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amplia Therapeutics position performs unexpectedly, PsyBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PsyBio Therapeutics will offset losses from the drop in PsyBio Therapeutics' long position.
The idea behind Amplia Therapeutics Limited and PsyBio Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
CEOs Directory
Screen CEOs from public companies around the world
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments